Chart Acquisition (CACG) 10-Q 10 Nov 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 10, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'Chart Acquisition Corp.	'
Entity Central Index Key	'0001527349	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	8,785,309

Condensed_Balance_Sheets

Condensed Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
Current Assets:	'	'
Cash	$469,897	$118,706
Due from Sponsor	660	409
Prepaid Expenses	5,000	87,252
Total Current Assets	475,557	206,367
Non-current Assets:	'	'
Cash and Investments Held in Trust Account	65,353,648	75,048,721
Total Assets	65,829,205	75,255,088
Current Liabilities:	'	'
Accounts Payable and Accrued Expenses	1,838,244	194,115
Due to Affiliate	1,442	1,442
Notes Payable, Sponsor	709,168	'
Notes Payable, Affiliate of Sponsor	440,832	'
Total Current Liabilities	2,989,686	195,557
Deferred Underwriting Fee	2,343,750	2,343,750
Warrant Liability	4,327,015	5,906,250
Total Liabilities	9,660,451	8,445,557
Common stock subject to possible redemption; 5,116,876 and 6,180,953 shares at $10.00 per share at September 30, 2014 and December 31, 2013, respectively	51,168,753	61,809,530
Stockholders' Equity:	'	'
Preferred Stock, $.0001 par value; 1,000,000 shares authorized, no shares issued and outstanding	'	'
Common Stock, $.0001 par value; 29,000,000 shares authorized; 3,668,433 and 3,569,047 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively (excluding 5,116,876 and 6,180,953 shares subject to possible redemption, respectively)	367	357
Additional Paid-in Capital	7,078,919	6,085,062
Deficit Accumulated During Development Stage	-2,079,285	-1,085,418
Total Stockholders' Equity	5,000,001	5,000,001
Total Liabilities and Stockholders' Equity	$65,829,205	$75,255,088

Condensed_Balance_Sheets_Paren

Condensed Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Statement Of Financial Position [Abstract]	'	'
Common stock redemption shares	5,116,876	6,180,953
Common stock redemption, price per share	$10	'
Preferred stock, Par value	$0.00	$0.00
Preferred Stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	'	'
Preferred stock, shares outstanding	'	'
Common stock, Par value	$0.00	$0.00
Common stock, shares authorized	29,000,000	29,000,000
Common stock, shares issued	3,668,433	3,569,047
Common stock, shares outstanding	3,668,433	3,569,047

Condensed_Statements_of_Operat

Condensed Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended		38 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014
Statements Of Operations [Abstract]	'	'	'	'	'
Revenue	'	'	'	'	'
Formation and Operating Costs	'	'	'	'	3,996
General and Administrative Expenses	1,232,291	486,057	2,585,260	831,401	3,715,403
Loss from Operations	-1,232,291	-486,057	-2,585,260	-831,401	-3,719,399
Other Income (expense):	'	'	'	'	'
Interest Income	642	10,089	12,158	37,896	60,879
Change in Fair Value of Warrant Liability	791,735	-393,750	1,579,235	1,417,500	1,579,235
Net Income (Loss) Attributable to Common Stockholders	($439,914)	($869,718)	($993,867)	$623,995	($2,079,285)
Weighted Average Number of Common Shares Outstanding, basic and diluted	3,624,920	3,317,957	3,569,411	3,333,263	2,885,525
Basic and Diluted Net Income (Loss) per Share Attributable to Common Stockholders	($0.12)	($0.26)	($0.28)	$0.19	($0.72)

Condensed_Statements_of_Change

Condensed Statements of Changes in Stockholders' Equity (Unaudited) (USD $)	Total	Common Stock	Additional Paid-in Capital	Deficit Accumulated During Developmental Stage
Beginning Balance at Jul. 22, 2011	'	'	'	'
Beginning Balance, shares at Jul. 22, 2011	'	'	'	'
Sale of common stock issued to Sponsor on August 9, 2011 at $.011594 per share	25,000	216	24,784	'
Sale of common stock issued to Sponsor on August 9, 2011 at $.011594 per share, shares	'	2,156,250	'	'
Net loss attributable to common stockholders'	-527	'	'	-527
Ending Balance at Dec. 31, 2011	24,473	216	24,784	-527
Ending Balance, shares at Dec. 31, 2011	'	2,156,250	'	'
Sale of 7,500,000 units on December 19, 2012, net of underwriters' discount and offering expenses (including 6,289,495 subject to possible redemption)	70,026,199	750	70,025,449	'
Sale of 7,500,000 units on December 19, 2012, net of underwriters' discount and offering expenses (including 6,289,495 subject to possible redemption), shares	'	7,500,000	'	'
Reclassification of shares subject to possible redemption at redemption value on December 19, 2012	-62,894,948	-629	-62,894,319	'
Reclassification of shares subject to possible redemption at redemption value on December 19, 2012 ,shares	'	-6,289,495	'	'
Warrant liability recorded on December 19, 2012	-5,906,250	'	-5,906,250	'
Sale of 375,000 units to Sponsor on December 19, 2012	3,750,000	37	3,749,963	'
Sale of 375,000 units to Sponsor on December 19, 2012, shares	'	375,000	'	'
Change in shares subject to possible redemption, value	58,783	1	58,782	'
Change in shares subject to possible redemption, shares	'	5,878	'	'
Net loss attributable to common stockholders'	-58,256	'	'	-58,256
Ending Balance at Dec. 31, 2012	5,000,001	375	5,058,409	-58,783
Ending Balance, shares at Dec. 31, 2012	'	3,747,633	'	'
Forfeiture of Sponsor shares in connection with the underwriter's election to not exercise their over-allotment option	'	-28	28	'
Forfeiture of Sponsor shares in connection with the underwriter's election to not exercise their over-allotment option, shares	'	-281,250	'	'
Change in shares subject to possible redemption, value	1,026,635	10	1,026,625	'
Change in shares subject to possible redemption, shares	'	102,664	'	'
Net loss attributable to common stockholders'	-1,026,635	'	'	-1,026,635
Ending Balance at Dec. 31, 2013	5,000,001	357	6,085,062	-1,085,418
Ending Balance, shares at Dec. 31, 2013	'	3,569,047	'	'
Redemption of 964,691 shares	-9,646,910	-96	-9,646,814	'
Redemption of 964,691 shares, shares	964,691	-964,691	'	'
Change in shares subject to possible redemption, value	10,640,777	106	10,640,671	'
Change in shares subject to possible redemption, shares	'	1,064,077	'	'
Net loss attributable to common stockholders'	-993,867	'	'	-993,867
Ending Balance at Sep. 30, 2014	$5,000,001	$367	$7,078,919	($2,079,285)
Ending Balance, shares at Sep. 30, 2014	'	3,668,433	'	'

Condensed_Statements_of_Change1

Condensed Statements of Changes in Stockholders' Equity (Unaudited) (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 19, 2012	Aug. 09, 2011
Statement Of Stockholders' Equity [Abstract]	'	'	'	'	'
Common stock issued to Sponsor, per share price	'	'	'	'	$0.01
Number of sale of units including possible redemption shares	'	'	'	7,500,000	'
Number of shares subject to possible redemption	5,116,876	6,180,953	6,283,617	6,289,495	'
Sale of units to Sponsor	'	'	'	375,000	'
Stock redeemed during period shares	964,691	'	'	'	'

Condensed_Statements_of_Cash_F

Condensed Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended		38 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014
Cash Flows from Operating Activities	'	'	'
Net Income (Loss)	($993,867)	$623,995	($2,079,285)
Adjustment to reconcile net income (loss) to net cash used in operating activities:	'	'	'
Change in Fair Value of Warrant Liability	-1,579,235	-1,417,500	-1,579,235
Change in operating assets and liabilities:	'	'	'
Prepaid Expenses	82,252	-131,872	-5,000
Accounts Payable and Accrued Expenses	1,644,129	222,589	1,838,244
Interest - net of interest expense on Trust Account	-11,999	-37,896	-60,720
Interest withdrawn from Trust Account	60,162	'	60,162
Due to Affiliate	'	119	1,442
Due from Sponsor	-251	'	-660
Net Cash Used In Operating Activities	-798,809	-740,565	-1,825,052
Cash Flows from Investing Activities	'	'	'
Proceeds Deposited in Trust Account	'	'	-75,000,000
Net Cash Used in Investing Activities	'	'	-75,000,000
Cash Flows from Financing Activities	'	'	'
Proceeds from Sale of Common Stock to Sponsor	'	'	25,000
Proceeds from Public Offering	'	'	75,000,000
Proceeds from Issuance of Units to Sponsor	'	'	3,750,000
Proceeds from Note Payable, Affiliate of Sponsor	440,832	'	470,832
Principal Payments on Note Payable, Affiliate of Sponsor	'	'	-30,000
Proceeds from Note Payable, Sponsor	709,168	'	884,168
Principal Payments on Note Payable, Sponsor	'	'	-175,000
Payment of Offering Costs	'	-16,920	-2,630,051
Cash received into Trust Account for redemption of shares	9,646,910	'	9,646,910
Cash distribution from Trust Account for redemption of shares	-9,646,910	'	-9,646,910
Net Cash Provided by (Used in) Financing Activities	1,150,000	-16,920	77,294,949
Net Increase (Decrease) in Cash	351,191	-757,485	469,897
Cash at Beginning of the Period	118,706	1,147,464	'
Cash at Ending of the Period	469,897	389,979	469,897
Cash paid for:	'	'	'
Cash paid for state franchise tax	125,397	3,850	131,887
Supplemental Disclosure for Non-Cash Financing Activities	'	'	'
Adjustment for warrant liability in connection with the Public Offering	'	'	5,906,250
Deferred Underwriters' Fee	'	'	2,343,750
Accrued Expenses Included in Deferred Offering Costs	'	'	$16,920

Description_of_Organization_an

Description of Organization and Business Operations	9 Months Ended
	Sep. 30, 2014
Description of Organization and Business Operations and Basis of Presentation [Abstract]	'
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	'
	1.	DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
	Chart Acquisition Corp. (the “Company,” “we” or “us”) was incorporated in Delaware on July 22, 2011. The Company is a blank check company formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, exchangeable share transaction or similar business combination, one or more operating businesses or assets (a “business combination”). The Company has neither engaged in any operations nor generated any revenues to date. The Company has selected December 31 as its fiscal year end.
	At September 30, 2014, the Company had not commenced any operations. All activity through September 30, 2014 relates to the Company’s formation, initial public offering (“public offering”) described below in Note 4, and search for an initial business combination. See Note 11 for a description of the definitive agreements the Company entered into with Tempus Holdings, LLC (“Tempus”) to complete a business combination.
	The registration statement for the public offering was declared effective on December 13, 2012. The Company consummated the public offering on December 19, 2012 and received net proceeds of approximately $76,120,000 which includes $3,750,000 received from the private placement of 375,000 units to Chart Acquisition Group LLC, a Delaware limited liability Company (the “Sponsor”),  Joseph Wright, the Company’s chief executive officer and chairman of the board and Cowen Overseas Investment LP (“Cowen Overseas), an affiliate of Cowen and Company, LLC, one of the lead underwriters of the public offering and is net of approximately $2,630,000 of legal, accounting and underwriting fees. The Sponsor, Joseph Wright and Cowen Overseas each purchased units consisting of one share of common stock and a warrant to purchase one share of common stock (the “private placement”—Note 5).
	The Company’s management has broad discretion with respect to the specific application of the net proceeds of the public offering, although substantially all of the net proceeds of the public offering are intended to be generally applied toward effecting an initial business combination. Net proceeds of approximately $75,000,000 from the public offering and simultaneous private placements of the placement units (as described below in Note 4 and Note 5, respectively) were originally deposited in a trust account in the United States maintained by Continental Stock Transfer & Trust Company, acting as trustee. The proceeds held in the trust account are invested only in United States government treasury bills with a maturity of 180 days or less or in money market funds investing solely in United States Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended. Except for interest income earned on the trust account balance and released to us for working capital purposes and to pay taxes or dissolution expenses, if any, our amended and restated certificate of incorporation provides that none of the funds held in trust will be released from the trust account, until the earlier of (i) the consummation of our initial business combination; (ii) the expiration or termination of any tender offer conducted by the Company in connection with a proposed business combination not otherwise withdrawn; (iii) the redemption of the Company’s public shares if it is unable to consummate a business combination by September 13, 2014 (which date has been extended to March 13, 2015, as described in the Liquidation and Going Concern section below) subject to applicable law; or (iv) otherwise upon its liquidation or in the event its management resolves to liquidate the trust account and ceases to pursue the consummation of a business combination prior to September 13, 2014 (which date has been extended to March 13, 2015, as described in the Liquidation and Going Concern section below). The proceeds deposited in the trust account could become subject to the claims of our creditors, if any, which could have priority over the claims of the Company’s public stockholders.
	On September 5, 2014, the Company held a special meeting of stockholders (the “Meeting”). At the Meeting, the stockholders approved the following items: (i) an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Charter”) extending the date by which the Company must consummate its initial business combination from September 13, 2014 to March 13, 2015 (the “Business Combination Deadline Amendment”), (ii) an amendment to the Charter permitting stockholders to redeem their public shares for a pro rata portion of the funds available in the Company’s trust account (the “Trust Account”) and authorizing the Company and Continental Stock Transfer & Trust Company (“Continental”), the trustee of the Trust Account, to disburse such redemption payments (the “Redemption Rights Amendment”) and (iii) an amendment and restatement of the Investment Management Trust Agreement (as amended and restated, the “Trust Agreement”) between the Company and Continental permitting distributions from the Trust Account to those persons holding shares of common stock comprising part of the units sold in the Company’s initial public offering who wish to exercise their redemption rights in connection with the Meeting, and extending the date on which to liquidate the Trust Account in accordance with the Trust Agreement to March 13, 2015 (the “Trust Amendment”). The affirmative vote of holders of at least sixty-five percent of the issued and outstanding shares of the Company was required to approve each of the proposals.
	In connection with the Meeting, 964,691 shares were redeemed by the Company at a price of $10.00 per share, for a total redemption amount of $9,646,910. As of September 30, 2014, $65,353,648 was held in the Trust Account after the foregoing redemptions.
	Initial Business Combination
	For the purposes of consummating an initial business combination, the Company is not limited to a particular industry or geographic region, although its management team intends to focus on operating businesses in the following sectors: the provision and/or outsourcing of government services. The management team anticipates structuring a business combination to acquire 100% of the equity interests or assets of the target business or businesses. It may also, however, structure a business combination to acquire less than 100% of such interests or assets of the target business but will not acquire less than a controlling interest.
	The Company may consummate the initial business combination and conduct the redemptions without stockholder vote pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers, and may file tender offer documents with the Securities and Exchange Commission (“SEC”).
	Regardless of whether the Company holds a stockholder vote or a tender offer in connection with an initial business combination, public stockholders will have the right to redeem their shares for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the trust account, including interest but less taxes payable plus amounts released to fund working capital requirements. As a result, such shares will be recorded at redemption value and classified as temporary equity upon the completion of the public offering, in accordance with Financial Accounting Standards Board, (“FASB”) Accounting Standards Codification, (“ASC") Topic 480, “Distinguishing Liabilities from Equity.”
	The Company will not redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001 and, solely if it seeks stockholder approval, a majority of the outstanding shares of common stock voted are voted in favor of the initial business combination.
	Solely if the Company holds a stockholder vote to approve the initial business combination, and it does not conduct redemptions pursuant to the tender offer rules, it may enter into privately negotiated transactions to purchase public shares from stockholders who would otherwise elect to redeem their shares, with such purchases made using funds held in the trust account. All shares so purchased by the Company will be immediately cancelled.
	Liquidation and Going Concern
	If the Company does not consummate an initial business combination by March 13, 2015 it will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem all public shares then outstanding, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including any amounts representing interest earned on the trust account, less any interest released to the Company for working capital purposes, the payment of taxes or dissolution expenses, divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of its remaining stockholders and board of directors, dissolve and liquidate, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The mandatory liquidation and subsequent dissolution raises substantial doubt about the Company's ability to continue as a going concern.
	As of September 30, 2014, we had a cash balance of $469,897, held outside of our trust account after issuance of $1,150,000 in Notes Payable, which is available for use by us to cover the costs associated with identifying a target business and negotiating a business combination and other general corporate uses. We believe that we have sufficient funds available to conduct the normal operations of the business. However, we may need to obtain additional financing from our Sponsor, Cowen Overseas and Joseph Wright to consummate our initial business combination with an operating business by March 13, 2015.

Basis_of_Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2014
Description of Organization and Business Operations and Basis of Presentation [Abstract]	'
BASIS OF PRESENTATION	'
	2.	BASIS OF PRESENTATION
	The accompanying condensed interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (“SEC”), and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of September 30, 2014 and December 31, 2013 and the results of operations for the for the three and nine months ended September 30, 2014 and 2013, and for the period from July 22, 2011 (date of inception) to September 30, 2014 and the cash flow activity for the nine months ended September 30, 2014 and 2013 and for the period from July 22, 2011 (date of inception) to September 30, 2014. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. The results of operations for the period ended September 30, 2014 is not necessarily indicative of the results of operations to be expected for a full fiscal year.
	During the six months ended June 30, 2014, the Company identified and corrected an error related to the accounting for the Company’s changes in amounts subject to possible redemption for the years ended December 31, 2013 and 2012. This treatment has been consistently applied for the period ended September 30, 2014. The Company determined that its changes in amounts subject to possible redemption should have been accounted for as an adjustment to additional paid-in capital instead of as an adjustment to accumulated deficit. There was no change in previously reported total assets, total liabilities, common stock subject to possible redemption or net loss attributable to common shares for any of the periods. The accompanying condensed financial statements were revised to reflect a balance in accumulated deficit with a corresponding increase of additional paid-in capital as of December 31, 2013 and 2012.  In accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin Nos. 99 and 108 (“SAB 99” and “SAB 108”), the Company evaluated these errors and, based on an analysis of quantitative and qualitative factors, determined that they were not material to each of the prior reporting periods affected and no amendments of previously filed 10-Q or 10-K reports with the SEC are required. We have reassessed the effect of this error as of September 30, 2014 and believe no further adjustment is required.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Summary of Significant Accounting Policies [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	3	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Development Stage Company
	The Company complies with the reporting requirements of ASC Topic 915, “Development Stage Entities.” At September 30, 2014, the Company has not commenced any operations nor generated revenue to date. All activity through September 30, 2014, relates to the Company’s formation, the public offering and search for an initial business combination. Following the public offering, the Company will not generate any operating revenues until after completion of an initial business combination, at the earliest. The Company generates non-operating income in the form of interest income on the designated trust account after the public offering.
	Net Income (Loss) Per Common Share
	Net income (loss) per common share is computed by dividing net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding for the period. For all periods presented, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common shares and then share in the earnings of the Company. As a result, diluted income (loss) per common share is the same as basic loss per share for periods presented.
	Securities Held in Trust Account
	Investment securities consist of United States Treasury securities. The Company classifies its securities as held-to-maturity in accordance with FASB ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts.
	A decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities' fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry the investee operates in.
	Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion is included in the “interest income” line item in the statements of operations. Interest income is recognized when earned.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
	Income Tax
	The Company complies with the accounting and reporting requirements of FASB ASC 740, “Income Taxes”, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for the differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. A valuation allowance is established when necessary to reduce deferred tax assets when it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized. At September 30, 2014 and December 31, 2013, the Company has a net deferred tax asset of approximately $728,000 and $378,000, respectively, related to net operating loss carry forwards which begin to expire in 2032, change in fair value of warrant liability, and start-up costs. Management has determined that a full valuation allowance of the deferred tax asset is appropriate at this time.
	FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes” (FIN 48) (now incorporated into FASB ASC 740, Income Taxes), sets out a consistent framework to determine the appropriate level of tax reserves to maintain for uncertain tax positions. This interpretation uses a two-step approach wherein a tax benefit is recognized if a position is more-likely-than-not to be sustained upon examination by taxing authorities. The amount of the benefit is then measured to be the highest tax benefit that is greater than 50% likely to be realized. Based on its analysis, the Company has determined that it has not incurred any liability for unrecognized tax benefits as of September 30, 2014. The Company’s conclusions may be subject to review and adjustment at a later date based on factors including, but not limited to, on-going analyses of and changes to tax laws, regulations and interpretations thereof. The Company files an income tax return in the U.S. federal jurisdiction, and may file income tax returns in various U.S. states and foreign jurisdictions.  The Company recognizes interest and penalties related to unrecognized tax benefits in interest expense and other expenses, respectively. No interest expense or penalties have been recognized as of September 30, 2014.
	The Company may be subject to potential examination by U.S. federal, U.S. states or foreign jurisdiction authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with U.S. federal, U.S. state and foreign tax laws.
	Fair Value of Financial Instruments
	The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures”, approximates the carrying amounts represented in the accompanying condensed balance sheets.
	Recent Accounting Pronouncements
	In June 2014, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2014-10, which eliminated certain financial reporting requirements of companies previously identified as “Development Stage Entities” (Topic 915). The amendments in this ASU simplify accounting guidance by removing all incremental financial reporting requirements for development stage entities. The amendments also reduce data maintenance and, for those entities subject to audit, audit costs by eliminating the requirement for development stage entities to present inception-to-date information in the statements of income, cash flows, and shareholder equity. Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued (public business entities) or made available for issuance (other entities). Upon adoption, entities will no longer present or disclose any information required by Topic 915. For public business entities, those amendments are effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. The Company will be adopting this standard in future filings.
	Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
	Concentration of Credit Risk
	Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
	Redeemable Common Stock
	As discussed in Note 1, all of the common shares sold as part of the units in the public offering and still outstanding as of September 30, 2014, contain a redemption feature which allows for the redemption of common shares under the Company’s liquidation or tender offer/stockholder approval provisions. In accordance with ASC Topic 480 "Distinguishing Liabilities from Equity", redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity.
	Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC Topic 480. Although the Company does not specify a maximum redemption threshold, its charter provides that in no event will they redeem its public shares in an amount that would cause its net tangible assets (stockholders’ equity) to be less than $5,000,001.
	The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of the security to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock shall be affected by charges against the par value of common stock and retained earnings, or in the absence of retained earnings, by charges against additional paid-in capital in accordance with ASC Topic 480-10-S99. Accordingly, at September 30, 2014 and December 31, 2013, public shares of 5,116,876 and 6,180,953, respectively, are classified outside of permanent equity at its redemption value. The redemption value is equal to the pro rata share of the aggregate amount then on deposit in the Trust Account, including any amounts representing interest earned on the trust account, less any interest released to the Company for working capital purposes or the payment of taxes (approximately $10.00 at September 30, 2014).

Public_Offering

Public Offering	9 Months Ended
	Sep. 30, 2014
Public Offering [Abstract]	'
PUBLIC OFFERING	'
	4	PUBLIC OFFERING
	The public offering called for the Company to offer for sale 7,500,000 units at a purchase price of $10.00 per unit. Each unit consists of (i) one share of the Company’s common stock, $0.0001 par value (“common stock”), and (ii) one warrant to purchase one share of common stock (“warrant”). Each warrant entitles the holder to purchase one share of the Company’s common stock at a price of $11.50. Each warrant will become exercisable on the later of 30 days after the completion of an initial business combination and one year from the date of the prospectus for the public offering, and will expire five years from the date of the initial business combination, or earlier upon redemption or liquidation. The Company may redeem the warrants at a price of $0.01 per warrant upon 30 days’ prior written notice after the warrants become exercisable, only in the event that the last sales price of the common stock (or the closing bid price of the common stock in the event shares of our common stock are not traded on any specific trading day) equals or exceeds $17.50 per share for any 20 trading days within a 30 trading day period ending three business days before the notice of redemption is given. In the event that a registration is not effective at the time of exercise, the holders of the warrants shall not be entitled to exercise such warrants (except on a cashless basis under certain circumstances) and in no event (whether in the case of a registration statement not being effective or otherwise) will the Company be required to net cash settle the warrants and the warrants will expire worthless.

Related_Party_Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]	'
RELATED PARTY TRANSACTIONS	'
	5	RELATED PARTY TRANSACTIONS
	Private Placements
	On August 9, 2011, the Company issued to its Sponsor in a private placement 2,156,250 shares (after giving effect to its 0.75-for-1 reverse stock split effectuated on July 10, 2012) of restricted common stock for an aggregate purchase price of $25,000, of which 281,250 shares were forfeited in January 2013. The initial shares will not be released from transfer restrictions until: (i) one year after the consummation of the Company’s initial business combination or earlier if, subsequent to its business combination, the last sales price of its common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after its initial business combination, or (ii) the date on which it consummates a liquidation, merger, stock exchange or other similar transaction after its initial business combination that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property.
	The Sponsor, Joseph Wright and Cowen Overseas purchased, simultaneously with the closing of the public offering, 375,000 units (the “placement units”) from the Company at a price of $10.00 per unit, each unit consisting of one share of common stock (“placement shares”) and a warrant to purchase one share of common stock (“placement warrants”) (for an aggregate purchase price of $3,750,000) in private placement pursuant to Section 4(2) of the Securities Act of 1933, as amended. The placement warrants are identical to the warrants sold in the public offering except that, (i) if held by the initial holders or their permitted assigns, they (a) may be exercised for cash or on a cashless basis at the option of the holder; and (b) will not be redeemable by the Company, and (ii) the placement warrants issued to Cowen Overseas, so long as held by Cowen Overseas or any of its related persons under FINRA rules, expire five years from the effectiveness of the registration statement. In addition, the placement warrants and placement shares are subject to transfer restrictions until 30 days following the consummation of the initial business combination.
	The founder shares and the placement shares are identical to the shares of common stock included in the units that were sold in the public offering except that (i) the founder shares and the placement shares are subject to certain transfer restrictions as described above, and (ii) each of the initial stockholders and Cowen Overseas has agreed not to redeem any of the founder shares or placement shares, as the case may be, held by them in connection with the consummation of an initial business combination, and each has also waived its rights to participate in any redemption with respect to its initial shares and placement shares, as the case may be, if the Company fails to consummate an initial business combination.
	However, each of the initial stockholders and Cowen Overseas (as applicable) will be entitled to redeem any public shares it acquires in or after the public offering in the event the Company fails to consummate an initial business combination within the required time period.
	In connection with a stockholder vote to approve an initial business transaction, if any, each of the Company’s initial stockholders have agreed to vote their initial shares and/or placement shares, as the case may be, in favor of the initial business transaction. In addition, the Company’s initial stockholders, officers and directors have each also agreed to vote any shares of common stock acquired in the public offering or in the aftermarket in favor of the initial business transaction submitted to stockholders for approval, if any.
	The initial holders of the Company’s founder shares and placement shares and their permitted transferees are entitled to registration rights pursuant to a registration rights agreement signed on the date of the Company’s prospectus relating to the public offering.
	Such holders are entitled to demand registration rights and certain “piggy-back” registration rights with respect to the initial shares, the placement shares, the placement warrants and the shares of common stock underlying the placement warrants, commencing, in the case of the initial shares, one year after the consummation of the initial business combination and commencing, in the case of the placement shares, the placement warrants and the shares of common stock underlying the placement warrants, 30 days after the consummation of the initial business combination.
	Note Payable to Sponsor
	The Company issued a $246,667 unsecured non-interest bearing promissory note to our Sponsor on February 10, 2014. The proceeds from the loan were used for working capital purposes of the Company. The principal balance of the note was initially payable on the earlier of (i) the date that is nine (9) months from the date of the note or (ii) the date on which the Company consummates an initial business combination. The notes are convertible at the Sponsor’s election upon the consummation of an initial business combination. Upon such election, the notes will convert, at a price of $0.75 per share, into warrants to purchase common stock of the Company. These warrants would be identical to the placement warrants. On September 9, 2014, the promissory note was amended to provide that the payment date shall be the earlier of: (i) March 13, 2015 or (ii) the date on which the Company consummates its initial business combination.
	The Company issued a $215,834 unsecured non-interest bearing promissory note to our Sponsor on September 9, 2014. The proceeds from the loan were used for working capital purposes of the Company. The principal balance of the note is payable on the earlier of (i) March 13, 2015 or (ii) the date on which the Company consummates an initial business combination. The notes are convertible at the Sponsor’s election upon the consummation of an initial business combination. Upon such election, the notes will convert, at a price of $0.75 per share, into warrants to purchase common stock of the Company. These warrants would be identical to the placement warrants.
	The Company issued a $246,667 unsecured non-interest bearing promissory note to our Sponsor on September 9, 2014. The proceeds from the loan were used for working capital purposes of the Company. The principal balance of the note is payable on the earlier of (i) March 13, 2015 or (ii) the date on which the Company consummates an initial business combination.
	Notes Payable to Affiliates
	The Company issued a $140,000 unsecured non-interest bearing promissory note to Cowen Overseas, an affiliate of one of our directors, on February 4, 2014. The proceeds from the loan were used for working capital purposes of the Company. The principal balance of the note was initially payable on the date of the consummation of an initial business combination. The notes are convertible at Cowen Overseas’ election upon the consummation of an initial business combination. Upon such election, the notes will convert, at a price of $0.75 per share, into warrants to purchase common stock of the Company. These warrants would be identical to the placement warrants. On September 9, 2014, the promissory note was amended to provide that the payment date shall be the earlier of: (i) March 13, 2015 or (ii) the date on which the Company consummates its initial business combination.
	The Company issued a $122,500 unsecured non-interest bearing promissory note to Cowen Overseas on September 9, 2014. The proceeds from the loan were used for working capital purposes of the Company. The principal balance of the note is payable on the earlier of (i) March 13, 2015 or (ii) the date on which the Company consummates an initial business combination. The notes are convertible at Cowen Overseas’ election upon the consummation of an initial business combination. Upon such election, the notes will convert, at a price of $0.75 per share, into warrants to purchase common stock of the Company. These warrants would be identical to the placement warrants.
	The Company issued a $140,000 unsecured non-interest bearing promissory note to Cowen Overseas on September 9, 2014. The proceeds from the loan were used for working capital purposes of the Company. The principal balance of the note is payable on the earlier of (i) March 13, 2015 or (ii) the date on which the Company consummates an initial business combination.
	The Company issued a $13,333 unsecured non-interest bearing promissory note to Joseph Wright, our Chairman and Chief Executive Officer, on February 7, 2014. The proceeds from the loan were used for working capital purposes of the Company. The principal balance of the note was initially payable on the date of the consummation of an initial business combination. The notes are convertible at Mr. Wright’s election upon the consummation of an initial business combination. Upon such election, the notes will convert, at a price of $0.75 per share, into warrants to purchase common stock of the Company. These warrants would be identical to the placement warrants. On September 9, 2014, the promissory note was amended to provide that the payment date shall be the earlier of: (i) March 13, 2015 or (ii) the date on which the Company consummates its initial business combination.
	The Company issued a $11,666 unsecured non-interest bearing promissory note to Mr. Wright on September 9, 2014. The proceeds from the loan were used for working capital purposes of the Company. The principal balance of the note is payable on the earlier of (i) March 13, 2015 or (ii) the date on which the Company consummates an initial business combination. The notes are convertible at Mr. Wright’s election upon the consummation of an initial business combination. Upon such election, the notes will convert, at a price of $0.75 per share, into warrants to purchase common stock of the Company. These warrants would be identical to the placement warrants.
	The Company issued a $13,333 unsecured non-interest bearing promissory note to Mr. Wright on September 9, 2014. The proceeds from the loan were used for working capital purposes of the Company. The principal balance of the note is payable on the earlier of (i) March 13, 2015 or (ii) the date on which the Company consummates an initial business combination.
	Due to Affiliate
	As of September 30, 2014 and 2013, the Chart Group L.P., an affiliate of the Sponsor, has paid certain offering, formation and operating costs on behalf of the Company. The total of such costs do not bear interest, and is due on demand. At September 30, 2014 and December 31, 2013, the total amount owed to the Chart Group L.P. is $1,442.
	Administrative Services
	The Company has agreed to pay the Chart Group L.P., an affiliate of the Sponsor a total of $10,000 per month for office space and general and administrative services. Services commenced on December 14, 2012, the date the securities of the Company were first listed on the Nasdaq Capital Market, and will terminate upon the earlier of the consummation by the Company of an initial business combination and the liquidation of the Company.  For the nine months ended September 30, 2014 and 2013 the Company incurred $90,000, pursuant to this service agreement. At September 30, 2014 and December 31, 2013, the Company has prepaid $5,000 relative to the service agreement.

Commitments

Commitments	9 Months Ended
	Sep. 30, 2014
Commitments [Abstract]	'
COMMITMENTS	'
	6.	COMMITMENTS
	The Company paid an underwriting discount of 2.750% (or $2,062,500) of the public unit offering price to the underwriters at the closing of the public offering, with an additional deferred fee of 3.125% (or $2,343,750) of the gross offering proceeds payable to the representatives of the underwriters upon the Company’s consummation of an initial business combination.

Warrant_Liability

Warrant Liability	9 Months Ended
	Sep. 30, 2014
Warrant Liability [Abstract]	'
WARRANT LIABILITY	'
	7	WARRANT LIABILITY
	The Company sold 7,875,000 Units in the December 19, 2012 Public Offering and private placement, which subsequently separated into one common share and one warrant.  The warrants expire five years after the date of the Company's initial Business Combination.  The warrants issued contain a cash settlement provision, as provided in the Warrant Agreement in the event of a Fundamental Transaction after the Initial Business Combination (see below), which requires liability treatment under ASC Topic 815-40-55-2.  ASC Topic 815-40-55-2 indicates that an event that causes a change of control of an issuer is not within the issuer's control and, therefore, a contract that requires net-cash settlement upon a change in control must be classified as an asset or liability.
	In connection with our initial public offering, our Sponsor, Mr. Wright and Cowen Overseas deposited an aggregate of $2,250,000 with Continental Stock Transfer & Trust Company into a segregated escrow account (representing $0.60 per warrant for up to 3,750,000 warrants). More specifically, the Sponsor deposited $1,387,500, Mr. Wright deposited $75,000 and Cowen Overseas deposited $787,500. The funds held in the escrow account were to be invested only in United States treasuries or in money market funds that invest solely in United States treasuries with a maturity of 180 days or less.
	In August 2014, our Sponsor, Mr. Wright and Cowen Overseas commenced a tender offer to purchase up to 3,750,000 of our issued and outstanding warrants at a purchase price of $0.30 per warrant in connection with the Meeting. A total of 7,700 warrants were validly tendered and not withdrawn in the tender offer. In September 2014 our Sponsor, Mr. Wright and Cowen Overseas accepted for purchase all such warrants for an aggregate purchase price of $2,310.
	Management used the quoted price for the valuation of the warrants to determine the warrant liability to be $4,327,015 and $5,906,250 as of September 30, 2014 and December 31, 2013.  This valuation is revised on a quarterly basis until the warrants are exercised or they expire, with the changes in fair value recorded in the condensed statements of operations.
	In the event of a Fundamental Transaction (as defined in the Warrant Agreement), which can only happen after the Company’s initial business combination, at the request of the holder delivered at any time through the date that is 30 days after the public disclosure of the consummation of such Fundamental Transaction by the Company pursuant to a Current Report on Form 8-K filed with the SEC, the Company (or the successor entity to the Company) shall purchase such Warrant from the holder by paying to the holder, within five trading days after such request, cash in an amount equal to the Black Scholes Value of the remaining unexercised portion of such Warrant on the date of such Fundamental Transaction. Any holder that receives cash pursuant to the immediately preceding sentence shall not receive any Alternate Consideration (as defined in the Warrant Agreement) from such transaction. For purposes hereof, "Black Scholes Value" means the value of the Warrant based on the Black Scholes Option Pricing Model obtained from the "OV" function on Bloomberg using (i) a price per share of common stock equal to the Closing Sale Price of the common stock for the trading day immediately preceding the date of consummation of the applicable Fundamental Transaction, (ii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of such Warrant as of such date of request, and (iii) an expected volatility equal to the greater of (A) forty percent (40%) and (B) the 30-day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately following the announcement of the Fundamental Transaction, (iv) a "Style" of "Warrant" and (v) a "Warrant type" of "Capped" where "Call cap" equals $17.50.

Investment_Held_in_Trust_Accou

Investment Held in Trust Account	9 Months Ended
	Sep. 30, 2014
Investment Held in Trust Account [Abstract]	'
INVESTMENT HELD IN TRUST ACCOUNT	'
	8	INVESTMENT HELD IN TRUST ACCOUNT
	Subsequent to the public offering, an amount of $75,000,000 (including $2,343,750 of deferred underwriters’ fee) of the net proceeds of the public offering and private placement, was deposited in a Trust Account and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940 have a maturity of 180 days or less until the earlier of (i) the consummation of a business combination, or (ii) liquidation of the Company. In connection with the Meeting, 964,691 shares were redeemed by the Company at a price of $10.00 per share, for a total redemption amount of $9,646,910. As of September 30, 2014, $65,353,648 was held in the Trust Account after the foregoing redemptions.
	As of September 30, 2014, investment securities in the Trust Account consist of $65,351,857 in United States money market mutual fund securities and another $1,791 is held as cash. As of December 31, 2013, investment securities in the Trust Account consist of $75,043,861 in United States Treasury Bills and another $4,860 is held as cash. The carrying value, excluding accrued interest income, gross unrealized holding gain (loss) and fair value of held to maturity securities at September 30, 2014 and December 31, 2013 are as follows:
			Carrying		Gross		Fair
			Value at		Unrealized		Value at
			September 30,		Holding		September 30,
			2014		Gain (Loss)		2014
	Held-to-maturity:
	U.S. Treasury money market mutual fund		$	65,351,857	$	-	$	65,351,857
			Carrying		Gross		Fair
			Value at		Unrealized		Value at
			December 31,		Holding		December 31,
			2013		Gain (Loss)		2013
	Held-to-maturity:
	U.S. Treasury Securities		$	75,043,861	$	1,138	$	75,044,999

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2014
Fair Value Measurements [Abstract]	'
FAIR VALUE MEASUREMENTS	'
	9.	FAIR VALUE MEASUREMENTS
	The Company complies with ASC Topic 820, “Fair Value Measurement” for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.
	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2014 and December 31, 2013, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Fair values determined by Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability:
			September 30,		Quoted		Significant		Significant
					Prices		Other		Other
					In Active		Observable		Unobservable
					Markets		Inputs		Inputs
	Description		2014		(Level 1)		(Level 2)		(Level 3)
	Assets:
	U.S. Treasury money market mutual fund held in Trust Account		$	65,351,857	$	65,351,857		—		—
	Liabilities:
	Warrant Liability		$	4,327,015		—	$	4,327,015		—
			December 31,		Quoted		Significant		Significant
					Prices		Other		Other
					In Active		Observable		Unobservable
					Markets		Inputs		Inputs
	Description		2013		(Level 1)		(Level 2)		(Level 3)
	Assets:
	U.S. Treasury Securities held in Trust Account		$	75,044,999	$	75,044,999		—		—
	Liabilities:
	Warrant Liability		$	5,906,250		—	$	5,906,250		—
	The fair values of the Company's investments held in the Trust Account and warrant liability are determined through market, observable and corroborated sources.

Stockholders_Equity

Stockholder's Equity	9 Months Ended
	Sep. 30, 2014
Stockholders' Equity [Abstract]	'
STOCKHOLDERS' EQUITY	'
	10	STOCKHOLDERS’ EQUITY
	Common Stock
	The Company is authorized to issue 29,000,000 shares of common stock. Holders of the Company’s common stock are entitled to one vote for each share.
	As of September 30, 2014 and December 31, 2013, there were 3,668,433 and 3,569,047 shares of common stock outstanding, respectively (excluding 5,116,876 and 6,180,953 shares subject to possible redemption, respectively).
	Preferred Stock
	The Company is authorized to issue 1,000,000 shares of preferred stock, in one or more series, with such designations, voting and other rights and preferences as may be determined from time to time by the board of directors. At September 30, 2014 and December 31, 2013, the Company has not issued any shares of preferred stock.

Business_Combinations

Business Combinations	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
BUSINESS COMBINATION	'
	11	BUSINESS COMBINATION
	On July 16, 2014, the Company announced that it signed definitive agreements to complete a business combination transaction with Tempus Intermediate Holdings, LLC ("Tempus").
	Pursuant to the definitive agreements, at the closing, a subsidiary of the Company will issue to the equity holders of Tempus equity interests exchangeable for approximately 10 million shares of the Company's common stock and will assume liabilities of Tempus, representing a total purchase price of $140 million, subject to adjustments as defined in the definitive agreements. The cash currently held in the Company's trust account will be used to fund any redemption by the Company’s public stockholders and the payment of transaction fees and expenses. Remaining cash will be used for working capital. For additional information regarding the business combination transaction with Tempus, please see the Current Report on Form 8-K filed by the Company on July 16, 1014.
	The Company's board of directors has unanimously approved the Tempus definitive agreements.  Completion of the transaction is subject to approval by the Company’s stockholders and other closing conditions.
	On September 5, 2014, the Company held the Meeting at which the stockholders approved the following items: (i) an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Charter”) extending the date by which the Company must consummate its initial business combination from September 13, 2014 to March 13, 2015 (the “Business Combination Deadline Amendment”), (ii) an amendment to the Charter permitting stockholders to redeem their public shares for a pro rata portion of the funds available in the Company’s trust account (the “Trust Account”) and authorizing the Company and Continental Stock Transfer & Trust Company (“Continental”), the trustee of the Trust Account, to disburse such redemption payments (the “Redemption Rights Amendment”) and (iii) an amendment and restatement of the Investment Management Trust Agreement (as amended and restated, the “Trust Agreement”) between the Company and Continental permitting distributions from the Trust Account to those persons holding shares of common stock comprising part of the units sold in the Company’s initial public offering who wish to exercise their redemption rights in connection with the Meeting, and extending the date on which to liquidate the Trust Account in accordance with the Trust Agreement to March 13, 2015 (the “Trust Amendment”). The affirmative vote of holders of at least sixty-five percent of the issued and outstanding shares of the Company was required to approve each of the proposals. The number of shares of common stock redeemed in connection with the Meeting was 964,691.
	In August 2014, our Sponsor, Mr. Wright and Cowen Overseas commenced a tender offer to purchase up to 3,750,000 of our issued and outstanding warrants at a purchase price of $0.30 per warrant in connection with the Meeting. A total of 7,700 warrants were validly tendered and not withdrawn in the tender offer. In September 2014, our Sponsor, Mr. Wright and Cowen Overseas accepted for purchase all such warrants for an aggregate purchase price of $2,310.

Subsequent_Event

Subsequent Event	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]	'
SUBSEQUENT EVENT	'
	12	SUBSEQUENT EVENT
	On March 4, 2014, we received a written notice from NASDAQ indicating that we were not in compliance with NASDAQ Listing Rule 5550(a)(3), which requires us to have at least 300 public holders for continued listing on the exchange. Subsequently, NASDAQ accepted our plan to regain compliance with such rule and provided us until September 2, 2014 to evidence such compliance. On September 5, 2014, we received a letter from NASDAQ stating that we had failed to evidence compliance with NASDAQ Listing Rule 5550(a)(3) by September 2, 2014, and that, accordingly, NASDAQ has determined to initiate procedures to delist our securities from NASDAQ, unless we appeal such determination on or before September 12, 2014.  We subsequently appealed NASDAQ’s delisting determination, which stayed any delisting actions until the issuance of a decision by a hearings panel. On October 16, 2014, we presented our appeal in front of a hearings panel. On October 23, 2014, NASDAQ advised us that the hearings panel had granted our request for continued listing subject to our completing the business combination with Tempus and achieving compliance with all NASDAQ initial listing requirements, including but not limited to NASDAQ Listing Rule 5550(a)(3), by March 4, 2015.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2014
Summary of Significant Accounting Policies [Abstract]	'
Development Stage Company	'
	Development Stage Company
	The Company complies with the reporting requirements of ASC Topic 915, “Development Stage Entities.” At September 30, 2014, the Company has not commenced any operations nor generated revenue to date. All activity through September 30, 2014, relates to the Company’s formation, the public offering and search for an initial business combination. Following the public offering, the Company will not generate any operating revenues until after completion of an initial business combination, at the earliest. The Company generates non-operating income in the form of interest income on the designated trust account after the public offering.
Net Income (Loss) Per Common Share	'
	Net Income (Loss) Per Common Share
	Net income (loss) per common share is computed by dividing net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding for the period. For all periods presented, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common shares and then share in the earnings of the Company. As a result, diluted income (loss) per common share is the same as basic loss per share for periods presented.
Securities Held in Trust Account	'
	Securities Held in Trust Account
	Investment securities consist of United States Treasury securities. The Company classifies its securities as held-to-maturity in accordance with FASB ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts.
	A decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities' fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry the investee operates in.
	Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion is included in the “interest income” line item in the statements of operations. Interest income is recognized when earned.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Income Tax	'
	Income Tax
	The Company complies with the accounting and reporting requirements of FASB ASC 740, “Income Taxes”, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for the differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. A valuation allowance is established when necessary to reduce deferred tax assets when it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized. At September 30, 2014 and December 31, 2013, the Company has a net deferred tax asset of approximately $728,000 and $378,000, respectively, related to net operating loss carry forwards which begin to expire in 2032, change in fair value of warrant liability, and start-up costs. Management has determined that a full valuation allowance of the deferred tax asset is appropriate at this time.
	FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes” (FIN 48) (now incorporated into FASB ASC 740, Income Taxes), sets out a consistent framework to determine the appropriate level of tax reserves to maintain for uncertain tax positions. This interpretation uses a two-step approach wherein a tax benefit is recognized if a position is more-likely-than-not to be sustained upon examination by taxing authorities. The amount of the benefit is then measured to be the highest tax benefit that is greater than 50% likely to be realized. Based on its analysis, the Company has determined that it has not incurred any liability for unrecognized tax benefits as of September 30, 2014. The Company’s conclusions may be subject to review and adjustment at a later date based on factors including, but not limited to, on-going analyses of and changes to tax laws, regulations and interpretations thereof. The Company files an income tax return in the U.S. federal jurisdiction, and may file income tax returns in various U.S. states and foreign jurisdictions.  The Company recognizes interest and penalties related to unrecognized tax benefits in interest expense and other expenses, respectively. No interest expense or penalties have been recognized as of September 30, 2014.
	The Company may be subject to potential examination by U.S. federal, U.S. states or foreign jurisdiction authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with U.S. federal, U.S. state and foreign tax laws.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures”, approximates the carrying amounts represented in the accompanying condensed balance sheets.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	In June 2014, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2014-10, which eliminated certain financial reporting requirements of companies previously identified as “Development Stage Entities” (Topic 915). The amendments in this ASU simplify accounting guidance by removing all incremental financial reporting requirements for development stage entities. The amendments also reduce data maintenance and, for those entities subject to audit, audit costs by eliminating the requirement for development stage entities to present inception-to-date information in the statements of income, cash flows, and shareholder equity. Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued (public business entities) or made available for issuance (other entities). Upon adoption, entities will no longer present or disclose any information required by Topic 915. For public business entities, those amendments are effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. The Company will be adopting this standard in future filings.
	Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
Concentration of Credit Risk	'
	Concentration of Credit Risk
	Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Redeemable Common Stock	'
	Redeemable Common Stock
	As discussed in Note 1, all of the common shares sold as part of the units in the public offering and still outstanding as of September 30, 2014, contain a redemption feature which allows for the redemption of common shares under the Company’s liquidation or tender offer/stockholder approval provisions. In accordance with ASC Topic 480 "Distinguishing Liabilities from Equity", redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity.
	Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC Topic 480. Although the Company does not specify a maximum redemption threshold, its charter provides that in no event will they redeem its public shares in an amount that would cause its net tangible assets (stockholders’ equity) to be less than $5,000,001.
	The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of the security to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock shall be affected by charges against the par value of common stock and retained earnings, or in the absence of retained earnings, by charges against additional paid-in capital in accordance with ASC Topic 480-10-S99. Accordingly, at September 30, 2014 and December 31, 2013, public shares of 5,116,876 and 6,180,953, respectively, are classified outside of permanent equity at its redemption value. The redemption value is equal to the pro rata share of the aggregate amount then on deposit in the Trust Account, including any amounts representing interest earned on the trust account, less any interest released to the Company for working capital purposes or the payment of taxes (approximately $10.00 at September 30, 2014).

Investment_Held_in_Trust_Accou1

Investment Held in Trust Account (Tables)	9 Months Ended
	Sep. 30, 2014
Investment Held in Trust Account [Abstract]	'
Schedule of gross unrealized holding gain (loss) and fair value of held to maturity securities	'
		Carrying		Gross		Fair
		Value at		Unrealized		Value at
		September 30,		Holding		September 30,
		2014		Gain (Loss)		2014
	Held-to-maturity:
	U.S. Treasury money market mutual fund	$	65,351,857	$	-	$	65,351,857
		Carrying		Gross		Fair
		Value at		Unrealized		Value at
		December 31,		Holding		December 31,
		2013		Gain (Loss)		2013
	Held-to-maturity:
	U.S. Treasury Securities	$	75,043,861	$	1,138	$	75,044,999

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Measurements [Abstract]	'
Schedule of Company's assets and liabilities that are measured at fair value on a recurring basis	'
		September 30,		Quoted		Significant		Significant
				Prices		Other		Other
				In Active		Observable		Unobservable
				Markets		Inputs		Inputs
	Description	2014		(Level 1)		(Level 2)		(Level 3)
	Assets:
	U.S. Treasury money market mutual fund held in Trust Account	$	65,351,857	$	65,351,857		—		—
	Liabilities:
	Warrant Liability	$	4,327,015		—	$	4,327,015		—
		December 31,		Quoted		Significant		Significant
				Prices		Other		Other
				In Active		Observable		Unobservable
				Markets		Inputs		Inputs
	Description	2013		(Level 1)		(Level 2)		(Level 3)
	Assets:
	U.S. Treasury Securities held in Trust Account	$	75,044,999	$	75,044,999		—		—
	Liabilities:
	Warrant Liability	$	5,906,250		—	$	5,906,250		—

Description_of_Organization_an1

Description of Organization and Business Operations (Details) (USD $)	1 Months Ended	9 Months Ended	38 Months Ended
	Dec. 19, 2012	Sep. 30, 2014	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Jul. 22, 2011
Description of Organization and Business Operations (Textual)	'	'	'	'	'	'	'	'	'
Proceeds from Public Offering	'	'	$75,000,000	'	'	'	'	'	'
Number of units sold	7,875,000	'	'	'	'	'	'	'	'
Sale of stock, description	'Which subsequently separated into one common share and one warrant.	'	'	'	'	'	'	'	'
Maximum maturity period of U S treasury bill	'	'180 days	'	'	'	'	'	'	'
Description of anticipated equity method investment	'	'	'	'	'	'	'	'	'
		The management team anticipates structuring a business combination to acquire 100% of the equity interests or assets of the target business or businesses. It may also, however, structure a business combination to acquire less than 100% of such interests or assets of the target business but will not acquire less than a controlling interest.
Net tangible assets required	'	5,000,001	'	'	'	'	'	'	'
Cash and cash equivalent balance, held outside of our trust account	'	469,897	469,897	118,706	389,979	615,106	788,320	1,147,464	'
Notes payable	'	1,150,000	1,150,000	'	'	'	'	'	'
Total redemption amount	'	-9,646,910	'	'	'	'	'	'	'
Number of redeemption shares	'	964,691	'	'	'	'	'	'	'
Common stock redemption, price per share	'	$10	$10	'	'	'	'	'	'
Amount held in Trust Account after the foregoing redemptions	'	65,353,648	65,353,648	75,048,721	'	'	'	'	'
Private Placement [Member]	'	'	'	'	'	'	'	'	'
Description of Organization and Business Operations (Textual)	'	'	'	'	'	'	'	'	'
Proceeds from Public Offering	76,120,000	'	'	'	'	'	'	'	'
Amount received from private placement	3,750,000	'	'	'	'	'	'	'	'
Number of units sold	375,000	'	'	'	'	'	'	'	'
Sale of stock, description	'Each purchased units consisting of one share of common stock and a warrant to purchase one share of common stock.	'	'	'	'	'	'	'	'
Legal, accounting and underwriting fees	2,630,000	'	'	'	'	'	'	'	'

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details) (USD $)	9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Summary of Significant Accounting Policies (Textual)	'	'
Deferred tax asset net operating loss carry forwards	$728,000	$378,000
Operating loss carry forwards expiration period	31-Dec-32	'
Federal depository insurance coverage	250,000	'
Net tangible assets required	$5,000,001	'
Number of shares classified to temporary equity	5,116,876	6,180,953
Temporary equity, redemption price per share	$10	'

Public_Offering_Details

Public Offering (Details) (USD $)	1 Months Ended			9 Months Ended
	Dec. 19, 2012	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2014
				IPO [Member]	Warrant [Member]
Public Offering (Textual)	'	'	'	'	'
Number of units sold	7,875,000	'	'	7,500,000	'
Purchase price per unit	'	'	'	$10	$11.50
Sale of stock, description	'Which subsequently separated into one common share and one warrant.	'	'	'Each unit consists of (i) one share of the Company's common stock, $0.0001 par value ("common stock"), and (ii) one warrant to purchase one share of common stock ("warrant").	'Each warrant will become exercisable on the later of 30 days after the completion of an initial business combination and one year from the date of the prospectus for the public offering, and will expire five years from the date of the initial business combination, or earlier upon redemption or liquidation.
Common stock, Par value	'	$0.00	$0.00	'	'
Warrant redemption price	'	'	'	'	$0.01
Warrant redemption, description	'	'	'	'	'The Company may redeem the warrants at a price of $0.01 per warrant upon 30 days' prior written notice after the warrants become exercisable, only in the event that the last sales price of the common stock (or the closing bid price of the common stock in the event shares of our common stock are not traded on any specific trading day) equals or exceeds $17.50 per share for any 20 trading days within a 30 trading day period ending three business days before the notice of redemption is given.

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)

1 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

Dec. 19, 2012

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Aug. 09, 2011

Sep. 30, 2014

Sep. 09, 2014

Feb. 10, 2014

Sep. 09, 2014

Sep. 09, 2014

Feb. 04, 2014

Feb. 07, 2014

Sep. 09, 2014

Sep. 09, 2014

Sep. 09, 2014

Private Placement [Member]

Private Placement [Member]

Note Payable to Sponsor [Member]

Note Payable to Sponsor [Member]

Note Payable to Sponsor One [Member]

Notes Payable to Affiliates [Member]

Notes Payable to Affiliates [Member]

Notes Payable to Affiliates [Member]

Notes Payable to Affiliates One [Member]

Notes Payable to Affiliates Two [Member]

Notes Payable to Affiliates Three [Member]

Related Party Transactions (Textual)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restricted common stock issued to its sponsor

'

'

'

'

2,156,250

'

'

'

'

'

'

'

'

'

'

Reverse stock split

'

'

'

'

'0.75-for-1

'

'

'

'

'

'

'

'

'

'

Aggregate purchase price of restricted common stock

'

'

'

'

$25,000

'

'

'

'

'

'

'

'

'

'

Restricted common stock forfeited

'

'

'

'

281,250

'

'

'

'

'

'

'

'

'

'

Share transfer restriction, description

'

'

'

'

'The initial shares will not be released from transfer restrictions until: (i) one year after the consummation of the Company's initial business combination or earlier if, subsequent to its business combination, the last sales price of its common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after its initial business combination, or (ii) the date on which it consummates a liquidation, merger, stock exchange or other similar transaction after its initial business combination that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property.

'

'

'

'

'

'

'

'

'

'

Sale price of common stock after business combination

'

'

'

'

$12

'

'

'

'

'

'

'

'

'

'

Number of units sold

7,875,000

'

'

'

'

375,000

'

'

'

'

'

'

'

'

'

Price per unit

'

'

'

'

'

$10

'

'

'

'

'

'

'

'

'

Unsecured promissory note issued

'

'

'

'

'

'

215,834

246,667

246,667

122,500

140,000

13,333

140,000

11,666

13,333

Purchase of common stock (into warrants) at a price per share

'

'

'

'

'

'

$0.75

$0.75

'

$0.75

$0.75

$0.75

'

$0.75

'

Unsecured promissory note payment tems

'

'

'

'

'

'

'The principal balance of the note is payable on the earlier of (i) March 13, 2015 or (ii) the date on which the Company consummates an initial business combination.

'On September 9, 2014, the promissory note was amended to provide that the payment date shall be the earlier of: (i) March 13, 2015 or (ii) the date on which the Company consummates its initial business combination.

'The principal balance of the note is payable on the earlier of (i) March 13, 2015 or (ii) the date on which the Company consummates an initial business combination.

'The principal balance of the note is payable on the earlier of (i) March 13, 2015 or (ii) the date on which the Company consummates an initial business combination.

'On September 9, 2014, the promissory note was amended to provide that the payment date shall be the earlier of: (i) March 13, 2015 or (ii) the date on which the Company consummates its initial business combination.

'On September 9, 2014, the promissory note was amended to provide that the payment date shall be the earlier of: (i) March 13, 2015 or (ii) the date on which the Company consummates its initial business combination.

'The principal balance of the note is payable on the earlier of (i) March 13, 2015 or (ii) the date on which the Company consummates an initial business combination.

'The principal balance of the note is payable on the earlier of (i) March 13, 2015 or (ii) the date on which the Company consummates an initial business combination.

'

The principal balance of the note is payable on the earlier of (i) March 13, 2015 or (ii) the date on which the Company consummates an initial business combination.

Due to Chart Group

'

1,442

'

1,442

'

'

'

'

'

'

'

'

'

'

'

Sponsor fee per month for office space and general and administrative services

'

10,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Service agreement expense

'

90,000

90,000

'

'

'

'

'

'

'

'

'

'

'

'

Prepaid expenses relative to service agreement

'

5,000

'

5,000

'

'

'

'

'

'

'

'

'

'

'

Amount received from private placement

'

'

'

'

'

$3,750,000

'

'

'

'

'

'

'

'

'

Commitments_Details

Commitments (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Commitments (Textual)	'
Underwriting discount, percentage	2.75%
Underwriting discount	$2,062,500
Deferred fee, percentage	3.13%
Deferred fee	$2,343,750

Warrant_Liability_Details

Warrant Liability (Details) (USD $)	1 Months Ended	9 Months Ended		9 Months Ended					1 Months Ended
	Dec. 19, 2012	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Aug. 31, 2014	Sep. 30, 2014
				IPO [Member]	Warrant [Member]	Sponsor [Member]	Mr. Wright [Member]	Cowen Overseas [Member]	Sponsor, Mr. Wright and Cowen Overseas [Member]	Sponsor, Mr. Wright and Cowen Overseas [Member]
						IPO [Member]	IPO [Member]	IPO [Member]	Warrant [Member]	Warrant [Member]
Warrants Liability (Textual)	'	'	'	'	'	'	'	'	'	'
Number of units sold	7,875,000	'	'	7,500,000	'	'	'	'	'	'
Sale of stock, description	'Which subsequently separated into one common share and one warrant.	'	'	'Each unit consists of (i) one share of the Company's common stock, $0.0001 par value ("common stock"), and (ii) one warrant to purchase one share of common stock ("warrant").	'Each warrant will become exercisable on the later of 30 days after the completion of an initial business combination and one year from the date of the prospectus for the public offering, and will expire five years from the date of the initial business combination, or earlier upon redemption or liquidation.	'	'	'	'	'
Warrants Term	'	'5 years	'	'	'	'	'	'	'	'
Escrow Deposit	'	'	'	$2,250,000	'	$1,387,500	$75,000	$787,500	'	'
Warrants outstanding	'	'	'	'	3,750,000	'	'	'	3,750,000	'
Warrants per share	'	'	'	'	$0.60	'	'	'	$0.30	'
Warrant maturity period	'	'	'	'	'180 days or less.	'	'	'	'	'
Total number of warrant	'	'	'	'	'	'	'	'	7,700	'
Aggregate purchase price	'	'	'	'	'	'	'	'	'	2,310
Warrant Liability	'	$4,327,015	$5,906,250	'	'	'	'	'	'	'
Period in which request can be made by warrant holder	'	'30 days	'	'	'	'	'	'	'	'
Period in which company shall purchase warrant	'	'5 days	'	'	'	'	'	'	'	'
Description of warrant based on the Black Scholes Option Pricing Model	'	'Warrant based on the Black Scholes Option Pricing Model obtained from the "OV" function on Bloomberg using (i) a price per share of common stock equal to the Closing Sale Price of the common stock for the trading day immediately preceding the date of consummation of the applicable Fundamental Transaction, (ii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of such Warrant as of such date of request, and (iii) an expected volatility equal to the greater of (A) forty percent (40%) and (B) the 30-day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately following the announcement of the Fundamental Transaction, (iv) a "Style" of "Warrant" and (v) a "Warrant type" of "Capped" where "Call cap" equals $17.50.	'	'	'	'	'	'	'	'

Investment_Held_in_Trust_Accou2

Investment Held in Trust Account (Details) (USD $)	12 Months Ended	9 Months Ended
	Dec. 31, 2013	Sep. 30, 2014
	US Treasury Securities [Member]	U.S. Treasury money market mutual fund [Member]
Summary of carrying value, excluding accrued interest income, gross unrealized holding loss and fair value of held to maturity securities	'	'
Held-to-maturity securities, Carrying value	$75,043,861	$65,351,857
Held-to-maturity securities, Gross Unrealized Holding Gain (Loss)	1,138	'
Held-to-maturity Securities, fair value	$75,044,999	$65,351,857

Investment_Held_in_Trust_Accou3

Investment Held in Trust Account (Details Textual) (USD $)	9 Months Ended		38 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Dec. 31, 2013
Investment Held in Trust Account (Textual)	'	'	'	'
Deferred Underwriters' Fee	'	'	$2,343,750	'
Proceeds from Public Offering	'	'	75,000,000	'
Investment securities held as cash	1,791	'	1,791	4,860
Number of redeemption shares	964,691	'	'	'
Total redemption amount	-9,646,910	'	'	'
Cash and Investments Held in Trust Account	65,353,648	'	65,353,648	75,048,721
US Treasury Securities [Member]	'	'	'	'
Investment Held in Trust Account (Textual)	'	'	'	'
Investment securities in the Company's Trust Account consist in United States Treasury Bills	'	'	'	75,043,861
U.S. Treasury money market mutual fund [Member]	'	'	'	'
Investment Held in Trust Account (Textual)	'	'	'	'
Investment securities in the Company's Trust Account consist in United States Treasury Bills	$65,351,857	'	$65,351,857	'

Fair_Value_Measurements_Detail

Fair Value Measurements (Details) (U.S. Treasury money market mutual fund held in Trust Account [Member], USD $)	Sep. 30, 2014	Dec. 31, 2013
Assets:	'	'
Assets, fair value	$65,351,857	$75,044,999
Liabilities:	'	'
Liabilities, fair value	4,327,015	5,906,250
Recurring basis [Member] | Quoted Prices In Active Markets (Level 1) [Member]	'	'
Assets:	'	'
Assets, fair value	65,351,857	75,044,999
Liabilities:	'	'
Liabilities, fair value	'	'
Recurring basis [Member] | Significant Other Observable Inputs (Level 2) [Member]	'	'
Assets:	'	'
Assets, fair value	'	'
Liabilities:	'	'
Liabilities, fair value	4,327,015	5,906,250
Recurring basis [Member] | Significant Other Unobservable Inputs (Level 3) [Member]	'	'
Assets:	'	'
Assets, fair value	'	'
Liabilities:	'	'
Liabilities, fair value	'	'

Stockholders_Equity_Details

Stockholders' Equity (Details)	9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Stockholders' Equity (Textual)	'	'
Common stock, shares authorized	29,000,000	29,000,000
Common stock, shares outstanding	3,668,433	3,569,047
Number of shares classified to temporary equity	5,116,876	6,180,953
Preferred Stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	'	'
Common stock voting right, description	'	'
	One vote for each share

Business_Combination_Details

Business Combination (Details) (USD $)	9 Months Ended		1 Months Ended		0 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Aug. 31, 2014	Sep. 30, 2014	Jul. 16, 2014
		Warrant [Member]	Sponsor, Mr. Wright and Cowen Overseas [Member]	Sponsor, Mr. Wright and Cowen Overseas [Member]	Tempus Intermediate Holdings, LLC [Member]
			Warrant [Member]	Warrant [Member]
Business Combinations (Textual)	'	'	'	'	'
Business combination, value of shares issued	'	'	'	'	$140,000,000
Business combination, number of shares issued	'	'	'	'	10,000,000
Number of redeemption shares	964,691	'	'	'	'
Aggregate purchase price	'	'	'	$2,310	'
Warrants outstanding	'	3,750,000	3,750,000	'	'
Total number of warrant	'	'	7,700	'	'
Warrant exercise price	'	$0.60	$0.30	'	'